Evidence map›Paper›PMID 34638204›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2021

[Comparison of serum GP73 and p62 measurement to predict short-term prognosis in patients with HBV-related acute-on-chronic liver failure].

W Gao, H Gao, C M Yin, S L Yang, X H Fan, C L Liu, X Q Li, N N Jia

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. CRISPR/Cas9 for hepatitis B virus infection treatment.Immunity, inflammation and disease · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

W GaoDepartment of Gastroenterology, the Second Hospitial of Shanxi Medical University, Taiyuan 030001, China.
H GaoDepartment of Gastroenterology, the Second Hospitial of Shanxi Medical University, Taiyuan 030001, China.
C M YinDepartment of Gastroenterology, the Second Hospitial of Shanxi Medical University, Taiyuan 030001, China.
S L YangDepartment of Gastroenterology, the Second Hospitial of Shanxi Medical University, Taiyuan 030001, China.
X H FanDepartment of Gastroenterology, the Second Hospitial of Shanxi Medical University, Taiyuan 030001, China.
C L LiuDepartment of Gastroenterology, the Second Hospitial of Shanxi Medical University, Taiyuan 030001, China.
X Q LiDepartment of Gastroenterology, the Second Hospitial of Shanxi Medical University, Taiyuan 030001, China.
N N JiaDepartment of Gastroenterology, the Second Hospitial of Shanxi Medical University, Taiyuan 030001, China.
Shanxi Medical University · CN

Funding

Shanxi Province Science Foundation for Youth (General Program) 201901D211494
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute-On-Chronic Liver FailureCarcinoma, HepatocellularLiver NeoplasmsHepatitis B virusHumansMembrane ProteinsPrognosisRetrospective StudiesMembrane ProteinsAutophagy-related proteinGolgi protein 73Hepatitis B virusLiver cirrhosisLiver failure

Identifiers

PMID34638204
PMCPMC12814030
OpenAlexW3205681550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.